The selection or rational design of a linker to join fusion protein domains is an important, under-explored area in recombinant fusion protein technology
Sourcing and applying multiple proteins into a specific biomarker assay involves a variety of moving pieces. Particularly during discovery stage research, where molecules of interest are constantly changing relative to hit identification. In other words, protein reagents play a significantly underrated role in developing early assays for biomarker analysis.
This article explores key material components and common oversight in recombinant protein approaches to help demonstrate factors effecting assay design. Additionally, we present a set of rational tactics for optimizing biomarker analysis through the procurement and criteria of laboratory/assay reagents.
Insight on various aspects of the biomarker workflow, such as:
kbDNA, INC.
125 Cambridgepark Dr.
Cambridge, MA 02140
Company
Contact Us
Phone:
+1 (781) 206-2235
Fax:
+1 (781) 206-2258
Email:
info@kbDNA.com
Useful Links
The kbDNA Inc. Quality Management Network is certified as conforming to ISO 9001:2015 standard. Request Certificate